Home » Generex Announces Approval to Market Noninjectible Insulin
Generex Announces Approval to Market Noninjectible Insulin
Generex Biotechnology Corporation, a leader in the area of buccal drug delivery, announced that Oral-lyn, its proprietary oral insulin spray formulation, has been approved for commercial marketing and sale by the Ecuadorian Ministry of Public Health for the treatment of both Type 1 and Type 2 diabetes.
Yahoo News (http://biz.yahoo.com/prnews/050503/sftu107.html?.v=8)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May